What's new

Human medicines European public assessment report (EPAR): Bortezomib Sun, bortezomib, Date of authorisation: 22/07/2016, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Bortezomib Sun, bortezomib, Date of authorisation: 22/07/2016, Revision: 14, Status: Authorised

May 6, 2025 - 15:57
 0
Human medicines European public assessment report (EPAR): Bortezomib Sun, bortezomib, Date of authorisation: 22/07/2016, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Bortezomib Sun, bortezomib, Date of authorisation: 22/07/2016, Revision: 14, Status: Authorised
Read More

Tags:

Previous Article

BorgWarner secures two dual-clutch programs in China

Next Article

India, UK conclude FTA, Double Contribution Convention

Related Posts

Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 29, 2025  0

CVMP Interested Parties’ meeting May 2025, European Medicines Agency, Amsterdam, the Netherlands, from 14 May 2025, 17:00 (CEST) to 14 May 2025, 19:00 (CEST)

CVMP Interested Parties’ meeting May 2025, European Med...

May 6, 2025  0

Agenda of the PRAC meeting 5-8 May 2025

May 6, 2025  0